Literature DB >> 16553031

Acute changes in clinical parameters and thyroid function peripheral markers following L-T4 withdrawal in patients totally thyroidectomized for thyroid cancer.

C Regalbuto1, C Alagona, R Maiorana, R Di Paola, M Cianci, G Alagona, S Sapienza, R Vigneri, V Pezzino.   

Abstract

After total thyroidectomy, differentiated thyroid cancer (DTC) patients have to undergo L-T4 withdrawal for measuring serum thyroglobulin and 131I whole-body scan (131I WBS) to evaluate residual/recurrent malignant disease. The aim of the present work was to study in these patients the effects of acute thyroid hormone deficiency on various target organs and tissues. Clinical parameters and thyroid function peripheral markers were evaluated in 20 DTC patients, both before and after L-T4 withdrawal. A 24-h urine collection, a fasting blood sample for laboratory examinations, a clinical score for hypothyroidism and cardiovascular, neurological and neuropsychological evaluations were carried out. After L-T4 withdrawal, the clinical score significantly increased, as well as total cholesterol, triglycerides, creatine kinase, lactate dehydrogenase, aspartate aminotransferase and alanine aminotransferase, whereas SHBG, osteocalcin and urine hydroxyproline levels significantly decreased. The acute thyroid hormone deficiency caused a systolic dysfunction of the left ventricle associated with an increase in systemic vascular resistance without cardiac contractility alterations. A significant increase in the left ventricular mass and thickness was also observed. Carpal tunnel syndrome appeared in 30% of patients and a significant reduction in the immediate auditive memorization and in attentive performance was also detected. These observations indicate that acute hypothyroidism causes significant clinical alterations of peripheral tissue function. In the follow-up of DTC patients, therefore, L-T4 withdrawal procedure should be restricted to cases where the cost/benefit ratio is favorable. Alternative procedures, such as the use of recombinant human TSH, should be used whenever possible.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16553031     DOI: 10.1007/bf03349174

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  59 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey.

Authors:  Christian Meier; Peter Trittibach; Merih Guglielmetti; Jean-Jacques Staub; Beat Müller
Journal:  BMJ       Date:  2003-02-08

3.  Carpal-tunnel syndrome associated with myxedema.

Authors:  D C PURNELL; D D DALY; P R LIPSCOMB
Journal:  Arch Intern Med       Date:  1961-11

4.  Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy.

Authors:  K H Dow; B R Ferrell; C Anello
Journal:  Thyroid       Date:  1997-08       Impact factor: 6.568

5.  Peripheral and central nervous system alterations in hypothyroidism: electrophysiological findings.

Authors:  E M Khedr; L F El Toony; M N Tarkhan; G Abdella
Journal:  Neuropsychobiology       Date:  2000-01       Impact factor: 2.328

Review 6.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

7.  Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study.

Authors:  R F Duyff; J Van den Bosch; D M Laman; B J van Loon; W H Linssen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

8.  The effects of hypothyroidism and thyroid replacement on the development of carpal tunnel syndrome.

Authors:  C F Palumbo; R M Szabo; S L Olmsted
Journal:  J Hand Surg Am       Date:  2000-07       Impact factor: 2.230

9.  Mechanisms of edema formation in myxedema--increased protein extravasation and relatively slow lymphatic drainage.

Authors:  H H Parving; J M Hansen; S L Nielsen; N Rossing; O Munck; N A Lassen
Journal:  N Engl J Med       Date:  1979-08-30       Impact factor: 91.245

10.  Moderate hypothyroidism in preparation for whole body 131I scintiscans and thyroglobulin testing.

Authors:  V Guimaraes; L J DeGroot
Journal:  Thyroid       Date:  1996-04       Impact factor: 6.568

View more
  9 in total

1.  Thyroid stimulating hormone and cognition during severe, transient hypothyroidism.

Authors:  Frank V Schraml; Pamela W Goslar; Leslie Baxter; Lori L Beason-Held
Journal:  Neuro Endocrinol Lett       Date:  2011       Impact factor: 0.765

2.  Comparison of conventional L-thyroxine withdrawal and moderate hypothyroidism in preparation for whole-body 131-I scan and thyroglobulin testing.

Authors:  I Marturano; M Russo; A Spadaro; A Latina; P Malandrino; C Regalbuto
Journal:  J Endocrinol Invest       Date:  2015-06-13       Impact factor: 4.256

3.  Endothelial function is not changed during short-term withdrawal of thyroxine in patients with differentiated thyroid cancer and low cardiovascular risk.

Authors:  Hyuk-Jae Chang; Kyung Won Kim; Sung Hee Choi; Soo Lim; Kyoung Un Park; Do Joon Park; Dong Joo Choi; Hak C Jang; Bo Youn Cho; Young Joo Park
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

4.  Diminished Quality of Life and Increased Brain Functional Connectivity in Patients with Hypothyroidism After Total Thyroidectomy.

Authors:  Yong-Wook Shin; Yun Mi Choi; Ho Sung Kim; Dae-Jin Kim; Hang Joon Jo; Brian F O'Donnell; Eun Kyung Jang; Tae Yong Kim; Young Kee Shong; Jin Pyo Hong; Won Bae Kim
Journal:  Thyroid       Date:  2016-04-11       Impact factor: 6.568

5.  Body Mass Index Is Associated with Hypercholesterolemia following Thyroid Hormone Withdrawal in Thyroidectomized Patients.

Authors:  Dong Yeob Shin; Kwang Joon Kim; Yongin Cho; Kyeong Hye Park; Sena Hwang; Woong Youn Chung; Eun Jig Lee
Journal:  Int J Endocrinol       Date:  2014-07-09       Impact factor: 3.257

6.  Gender impact on the correlation between thyroid function and serum lipids in patients with differentiated thyroid cancer.

Authors:  Xue Li; Zhaowei Meng; Jian Tan; Ming Liu; Qiang Jia; Guizhi Zhang; Yajing He; Qing Zhang; Li Liu; Kun Song; Qing He; Mei Zhu; Shen Wang; Jianping Zhang; Wei Zheng; Renfei Wang; Tianpeng Hu; Na Liu; Arun Upadhyaya
Journal:  Exp Ther Med       Date:  2016-09-14       Impact factor: 2.447

7.  Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study.

Authors:  Youhyun Song; Hye Sun Lee; Goeun Park; Sang-Wook Kang; Ji Won Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-27       Impact factor: 6.055

8.  Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study.

Authors:  Massimo Giusti; Lorenzo Mortara; Roberta Degrandi; Francesca Cecoli; Michele Mussap; Guido Rodriguez; Diego Ferone; Francesco Minuto
Journal:  Thyroid Res       Date:  2008-09-29

9.  Weight Changes in Patients with Differentiated Thyroid Carcinoma during Postoperative Long-Term Follow-up under Thyroid Stimulating Hormone Suppression.

Authors:  Seo Young Sohn; Ji Young Joung; Yoon Young Cho; Sun Mi Park; Sang Man Jin; Jae Hoon Chung; Sun Wook Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2015-08-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.